Table II.
Baseline clinical data.
| MACE group (n=39) | ND group (n=81) | P | |
|---|---|---|---|
| Male [case, (%)] | 26 (66.67) | 42 (51.85) | 0.125 |
| Age (year) | 68.65±6.56 | 62.58±7.12 | 0.021 |
| Smoking [case, (%)] | 18 (46.15) | 41 (50.61) | 0.740 |
| Hypertension [case, (%)] | 27 (71.01) | 39 (48.14) | 0.030* |
| Diabetes mellitus [case, (%)] | 22 (56.41) | 43 (53.09) | 0.730 |
| Coronary artery disease [case, (%)] | 20 (51.28) | 37 (45.68) | 0.560 |
| BMI (kg/m2) | 23.41±3.55 | 25.36±2.23 | 0.686 |
| WBC count (×106/L) | 12.35±3.41 | 9.25±2.68 | 0.001* |
| M (×106/L) | 0.57±0.25 | 0.48±0.13 | 0.680 |
| TC (mmol/L) | 4.55±0.88 | 2.35±0.37 | 0.001* |
| TG (mmol/L) | 2.69±0.29 | 1.60±0.35 | 0.006* |
| LDLC (mmol/L) | 2.43±0.25 | 2.49±0.24 | <0.001* |
| HDLC (mmol/L) | 2.25±0.33 | 1.14±0.36 | <0.001* |
| ApoA1 (mmol/L) | 17.18±0.37 | 6.85±0.53 | <0.001* |
| ApoB (mmol/L) | 1.13±0.25 | 0.75±0.06 | <0.001* |
| LP(a) (mmol/L) | 310.36±150.52 | 113.96±93.25 | <0.001* |
| UA (mmol/L) | 4.56±0.88 | 1.25±0.29 | <0.001* |
| Gensini score | 45.87±3.85 | 32.57±2.71 | 0.03* |
| MHR | 16.59±2.61 | 8.41±2.64 | <0.001* |